J. Burton

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

The Tissue-Engineered Vascular Graft—Past, Present, and Future

Epidemiology of traumatic spinal cord injury: trends and future implications

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis

Antithrombotic Therapy for Venous Thromboembolic Disease

Exercise Recommendations for Individuals with Spinal Cord Injury

Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis

A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease

Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years

The world health organization—International society of hypertension blood pressure lowering treatment trialists’ collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Total body water and percentage fat mass measurements using bioelectrical impedance analysis and anthropometry in spinal cord-injured patients

Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Survival and cause of death after traumatic spinal cord injury. A long-term epidemiological survey from Denmark

Overweight and obesity in women with physical disabilities: Associations with demographic and disability characteristics and secondary conditions

Spinal-cord injury

New Antithrombotic Drugs

Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery

New Antithrombotic Drugs

Health disparities among adults with physical disabilities or cognitive limitations compared to individuals with no disabilities in the United States

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Coronary bypass graft fate: Long-term angiographic study

The use of bioelectric impedance analysis to measure fluid compartments in subjects with chronic paraplegia11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

Aptamers as targeted therapeutics: current potential and challenges

Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery

Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging

Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): Relation to FXa-activity and influence of assay modifications

A comparison of 2 circuit exercise training techniques for eliciting matched metabolic responses in persons with paraplegia

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

The ReWalk Powered Exoskeleton to Restore Ambulatory Function to Individuals with Thoracic-Level Motor-Complete Spinal Cord Injury

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

On-Pump versus Off-Pump Coronary-Artery Bypass Surgery

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Bioelectrical impedance analysis?part I: review of principles and methods

Targeting Recovery: Priorities of the Spinal Cord-Injured Population

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

Alpha-Adrenergic Receptor Subtypes

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy

Factor Xa Inhibitors: Next-Generation Antithrombotic Agents

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Correlates of Saphenous Vein Graft Hyperplasia and Occlusion 1 Year After Coronary Artery Bypass Grafting

Sequential coronary bypass grafts. Long-term follow-up.

Efforts to Limit the Size of Myocardial Infarcts

Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis

Tolerance to organic nitrates: Clinical and experimental perspectives

Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure

Long-term outpatient vasodilator therapy of congestive heart failure

Aortocoronary Saphenous Vein Graft Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

Coronary artery disease and coronary bypass grafting in young men: Experience with 138 subjects 39 years of age and younger

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Metabolic Changes in Persons After Spinal Cord Injury

Coronary bypass graft fate

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

Perioperative myocardial infarction complicating coronary bypass

Sequential coronary bypass grafts

Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations

Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells

The role of vasodilator therapy in heart failure

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Aorta-coronary bypass in patients with coronary artery disease who do not have angina

Near-infrared fluorophores for biomedical imaging

The biology of platelet-derived growth factor

Desensitization to nitroglycerin in vascular smooth muscle from rat and human

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

The Pathogenesis of Atherosclerosis — An Update

Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial

Associations between serum lipids and indicators of adiposity in men with spinal cord injury

The Molecular Phenotype of Heart Transplant Biopsies: Relationship to Histopathological and Clinical Variables

Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin.

Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year.

Delayed diagnosis of symptomatic coronary artery disease in young men.

Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.

355